Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 9:12:89.
doi: 10.1186/1475-2875-12-89.

Two series of new semisynthetic triterpene derivatives: differences in anti-malarial activity, cytotoxicity and mechanism of action

Affiliations

Two series of new semisynthetic triterpene derivatives: differences in anti-malarial activity, cytotoxicity and mechanism of action

Gloria N S da Silva et al. Malar J. .

Abstract

Background: The discovery and development of anti-malarial compounds of plant origin and semisynthetic derivatives thereof, such as quinine (QN) and chloroquine (CQ), has highlighted the importance of these compounds in the treatment of malaria. Ursolic acid analogues bearing an acetyl group at C-3 have demonstrated significant anti-malarial activity. With this in mind, two new series of betulinic acid (BA) and ursolic acid (UA) derivatives with ester groups at C-3 were synthesized in an attempt to improve anti-malarial activity, reduce cytotoxicity, and search for new targets. In vitro activity against CQ-sensitive Plasmodium falciparum 3D7 and an evaluation of cytotoxicity in a mammalian cell line (HEK293T) are reported. Furthermore, two possible mechanisms of action of anti-malarial compounds have been evaluated: effects on mitochondrial membrane potential (ΔΨm) and inhibition of β-haematin formation.

Results: Among the 18 derivatives synthesized, those having shorter side chains were most effective against CQ-sensitive P. falciparum 3D7, and were non-cytotoxic. These derivatives were three to five times more active than BA and UA. A DiOC(6)(3) ΔΨm assay showed that mitochondria are not involved in their mechanism of action. Inhibition of β-haematin formation by the active derivatives was weaker than with CQ. Compounds of the BA series were generally more active against P. falciparum 3D7 than those of the UA series.

Conclusions: Three new anti-malarial prototypes were obtained from natural sources through an easy and relatively inexpensive synthesis. They represent an alternative for new lead compounds for anti-malarial chemotherapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Betulinic (BA) and ursolic (UA) acids.
Figure 2
Figure 2
Semisynthetic derivatives of series BA and UA. NS: Not synthesized.
Figure 3
Figure 3
Effect of derivatives on ΔΨm. Representative histograms showing the effect of higher concentration (25 μM) of derivatives 1e (3C), 1f (3D) and 2e (3E) on ΔΨm by FACS analysis. Negative control (3B) for the fluorescence intensity of parasites in the presence of 2 nM DiOC6(3) without any added inhibitors and with protonophore CCCP (5 μM) (3A).

References

    1. Pasternak ND, Dzikowski R. PfEMP1: an antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum. Int J Biochem Cell Biol. 2009;41:1463–1466. doi: 10.1016/j.biocel.2008.12.012. - DOI - PubMed
    1. Baumeister S, Winterberg M, Przyborski JM, Lingelbach K. The malaria parasite Plasmodium falciparum: cell biological peculiarities and nutritional consequences. Protoplasma. 2010;240:3–12. doi: 10.1007/s00709-009-0090-3. - DOI - PubMed
    1. Kayser O, Kiderlen AF, Croft SL. Natural products as antiparasitic drugs. Parasitol Res. 2003;90(Suppl 2):S55–S62. - PubMed
    1. Baird JK, Caneta-Miguel E, Masbar S, Bustos DG, Abrenica JA, Layawen AV, Calulut JM, Leksana B, Wignall FS. Survey of resistance to chloroquine of falciparum and vivax malaria in Palawan, The Philippines. Trans R Soc Trop Med Hyg. 1996;90:413–414. doi: 10.1016/S0035-9203(96)90528-3. - DOI - PubMed
    1. Carmargo LM, De Oliveira S, Basano S, Garcia CR. Antimalarials and the fight against malaria in Brazil. Ther Clin Risk Manag. 2009;5:311–317. - PMC - PubMed

Publication types

LinkOut - more resources